<Journal class="Journal" value="Endocrinol Diabetes Metab" /> <Page class="#txt" value="e00002"> <Page-2 class="#txt" value="" /> </Page> <Volume class="#txt" value="1" /> <Year class="Year" value="2018" /> </Reference> <Author class="Author" value="Berger JP" /> <Author class="Author" value="SinhaRoy R" /> <Author class="Author" value="Pocai A" /> <Author class="Author" value="Kelly TM" /> <Author class="Author" value="Scapin G" /> <Author class="Author" value="Gao YD" /> <Author class="Author" value="Pryor KAD" /> <Author class="Author" value="Wu JK" /> <Author class="Author" value="Eiermann GJ" /> <Author class="Author" value="Xu SS" /> <Author class="Author" value="Zhang X" /> <Author class="Author" value="Tatosian DA" /> <Author class="Author" value="Weber AE" /> <Author class="Author" value="Thornberry NA" /> <Author class="Author" value="Carr RD" /> <Medline class="Medline" value="30815539" /> <Abstract class="LongText" value="Berger_2018_Endocrinol.Diabetes.Metab_1_e00002" /> <Inhibitor class="Inhibitor" value="VildaSaxagliptin-analogue" /> <Inhibitor class="Inhibitor" value="Vildagliptin" /> <Structure class="Structure" value="6B1O" /> <Structure class="Structure" value="6B1E" /> <News class="News" value="SEPTEMBER-27-2017" /> </Paper>